UnitedHealth Group (UNH) and Amedisys (AMED) agreed to extend the deadline to complete their $3.3 billion merger, after the U.S. Department of Justice moved to block it.
The deal was announced in June of last year and had been expected to be completed this week, but the Department of Justice and state regulators moved last month to block it, arguing it could give UnitedHealth much control in the market for home health and hospice services. The case is currently in front of a federal judge in the District of Maryland.
In a regulatory filing Friday, Amedisys said the two firms waived their right to terminate the agreement until the 10th business day following the final order of the court, or Dec. 31, 2025, whichever comes first.
The new waiver includes a regulatory breakup fee of $275 million, which could go as high as $325 million, if the companies fail to divest certain assets by May 1.
Amedisys shares were up over 4% in early trading Friday following the news, while UnitedHealth shares were little changed.
TradingView
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。